Generation of GLI1, GLI2 and GLI3 knock-out melanoma cell lines via CRISPR/Cas9 gene editing (CROSBI ID 705092)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Kurtović, Matea ; Rinčić, Nikolina ; , Trnski, Diana ; Musani, Vesna ; Ozretić, Petar ; Sabol, Maja
engleski
Generation of GLI1, GLI2 and GLI3 knock-out melanoma cell lines via CRISPR/Cas9 gene editing
GLI transcription factors are the main mediators of Hedgehog-GLI (HH-GLI) signaling pathway. This pathway has an important role during embryogenic development, cellular proliferation, differentiation and stem cell maintenance. Its activity is essential not only for tumor growth but also for recurrence and metastatic growth. Targeting the HH-GLI signaling pathway is one of the recent approaches in cancer therapy. Our preliminary data suggest that melanoma cells harboring the BRAF mutation show a better response to GLI inhibition than cells with the NRAS mutation, suggesting a differential role for the HH signaling pathway in melanoma cells with different genetic background. In order to elucidate the role of GLI proteins in melanoma with these genetic backgrounds (BRAF mutation, NRAS mutation, no mutation), we constructed GLI1/2/3 knockout melanoma cell lines using CRISPR/Cas9 system. For this purpose, for each GLI protein, we designed two sgRNAs which guide the Cas9 protein to the specific sequences in the genome where they create a double stranded break. The designated sequence was the region near the ATG of GLI1/2/3 and the region near the end of the genes. These two breaks were repaired via homology-directed repair (HDR) with a help of HDR cassette that was transfected along with CRISPR/Cas9. After generation of KO cell lines, each maternal cell line and its KO for GLI1, GLI2 and GLI3 will be analyzed by RNA-seq to determine the changes in transcriptomes after knocking out a specific GLI protein. This analysis should provide us with the information of which genes are specifically regulated by each of the GLI proteins in each of the genetic background, which may provide insight into the observed differences between the cell lines with different genetic background.
CRISPR/Cas9 ; cancer ; melanoma ; knock-out
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
EACR21v 0165
2021.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
EACR 2021 Virtual Congress
poster
09.06.2021-12.06.2021
online